Letter from the Editor


Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at

SKU: 779. Category: .

Product Description

October is National Breast Cancer Awareness Month. We at PharmaVOICE thought it appropriate, therefore, to focus this month’s therapeutic specialty on this important area of research and treatment.
According to the American Cancer Society, breast cancer death rates are going down. The chance of dying from breast cancer is about 1 in 33. This decline is probably the result of finding the cancer earlier, as well as improved treatments introduced in the last decade. At the same time, the National Cancer Institute finds the estimated lifetime risk of breast cancer has gone up gradually over the past several decades.
The National Cancer Institute estimates that, based on current rates, 13.2% of women born today (1 in 8 women) will be diagnosed with breast cancer at some time in their lives. In the 1970s, the lifetime risk of being diagnosed with breast cancer in the United States was just under 10% (or 1 in 10 women)…